#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma recurrent Antiphospholipid antibodies Congenital leptin deficiency Multiple system atrophy Pulmonary arterial hypertension HER2 gene amplification Neuropathic arthropathy Acute graft versus host disease in intestine Desmoid tumour Small intestine adenocarcinoma Central nervous system neoplasm Short stature homeobox gene mutation Herpes simplex Thalassaemia Vascular malformation More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Treatment Mast cell activation syndrome – Trials in Disease Atypical haemolytic uraemic syndrome – Trials in Disease Chordoma – Trials in Disease Angiosarcoma – Treatment Basal cell naevus syndrome Antisynthetase syndrome – Basic Information Optic glioma – Trials in Disease Systemic mastocytosis – Diagnostics Mitochondrial myopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zibotentan Lutikizumab Donepezil Anhydrous Glucose Bp Upadacitinib Rivaroxaban Candesartan SODIUM TETRACHLOROPALLADATE Heparin Sodium Empasiprubart Sebetralstat Teropavimab OSIMERTINIB MESYLATE Bicalutamide Nizaracianine Triflutate [18F]Alf-Nota-Octreotide L-Histidine Hydrochloride Dersimelagon Phosphate Fluasterone Art6043 More therapies…

    Learn about Your Condition

    Neurodegenerative disorder Open angle glaucoma Richter's syndrome Coronary artery bypass Tertiary adrenal insufficiency Metabolic disorder Pyoderma gangrenosum Cerebellar ataxia Thyroid cancer Choreoathetosis Neurotrophic keratopathy Herpes simplex reactivation Dermatomyositis Candida infection Hodgkin's disease recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Levobupivacaine, Paracetamol, and Diclofenac for Pain Relief After Esophageal Lesion Procedure in Patients with Precancerous Esophageal Lesions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Levobupivacaine Hydrochloride
    • Diclofenac Sodium
    • Paracetamol
    The Netherlands

  • Study on the Effectiveness of Yttrium-90 Microspheres and Capecitabine for Patients with Operable Intrahepatic Cholangiocarcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Capecitabine
    France

  • Long-term safety study of Temferon (modified stem cells with interferon-α2) in patients previously treated for glioblastoma multiforme

    Recruiting

    1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Autologous Cd34+ Haematopoietic Stem And Progenitor Cells Transduced With A Lentiviral Vector Encoding The Interferon Alpha-2 Gene
    Italy

  • Study on F-18 PSMA-11 PET Imaging for Liver Cancer in Patients to Evaluate Survival

    Recruiting

    2 1 1
    Investigated Drugs:
    • Gozetotide Alf-18
    Belgium

  • Study on Antibiotic Prophylaxis with Piperacillin, Tazobactam, and Cefazolin for Burn Patients Undergoing Excision-Graft Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Cefazolin
    • Piperacillin Sodium
    • Tazobactam Sodium
    France

  • Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Clemastine
    • Placebo
    Germany
Previous Page
1 … 349 350 351 352 353 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!